Policy | September 28, 2024
India releases revised operational guidelines of non-alcoholic fatty liver disease
India has taken the lead in recognising NAFLD as a major non-communicable disease
India has taken the lead in recognising NAFLD as a major non-communicable disease
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
Subscribe To Our Newsletter & Stay Updated
